• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Nabawi, A., Elwagih, H., Farag, M., Mansy, M. (2022). HASHIMOTO’S THYROIDITIS AS A RISK FACTOR OF COMPLICATIONS OF TOTAL THYROIDECTOMY.. ALEXMED ePosters, 4(4), 15-16. doi: 10.21608/alexpo.2022.170386.1492
Ayman Sameh Nabawi; Hatem Fawzy Elwagih; Mostafa Mahmoud Farag; Mohamed M. Mansy. "HASHIMOTO’S THYROIDITIS AS A RISK FACTOR OF COMPLICATIONS OF TOTAL THYROIDECTOMY.". ALEXMED ePosters, 4, 4, 2022, 15-16. doi: 10.21608/alexpo.2022.170386.1492
Nabawi, A., Elwagih, H., Farag, M., Mansy, M. (2022). 'HASHIMOTO’S THYROIDITIS AS A RISK FACTOR OF COMPLICATIONS OF TOTAL THYROIDECTOMY.', ALEXMED ePosters, 4(4), pp. 15-16. doi: 10.21608/alexpo.2022.170386.1492
Nabawi, A., Elwagih, H., Farag, M., Mansy, M. HASHIMOTO’S THYROIDITIS AS A RISK FACTOR OF COMPLICATIONS OF TOTAL THYROIDECTOMY.. ALEXMED ePosters, 2022; 4(4): 15-16. doi: 10.21608/alexpo.2022.170386.1492

HASHIMOTO’S THYROIDITIS AS A RISK FACTOR OF COMPLICATIONS OF TOTAL THYROIDECTOMY.

Article 3, Volume 4, Issue 4, December 2022, Page 15-16  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2022.170386.1492
View on SCiNiTO View on SCiNiTO
Authors
Ayman Sameh Nabawi1; Hatem Fawzy Elwagih2; Mostafa Mahmoud Farag3; Mohamed M. Mansy email 2
1Department of Surgery, Faculty of Medicine, Alexandria University
2Head and Neck and Endocrine Unit, Surgery Department, Faculty of Medicine, Alexandria University
3Head and Neck and Endocrine unit, Surgery department, Faculty of medicine, Alexandria university
Abstract
Thyroid diseases are one of the most prevalent endocrinopathies globally. Most of the thyroid diseases treated surgically especially when medical treatment fails, cosmetic purposes or when thyroid cancer is suspected. Hashimoto's thyroiditis (HT), a type of chronic lymphocytic thyroiditis, is the most common autoimmune thyroid condition. Histologically, the disease is characterized by an extensive lymphocytic infiltrate in the thyroid and follicular atrophy with increased fibrosis.The diagnosis is primarily made on the basis of serum autoantibodies against thyroperoxidase and/or thyroglobulin, which may precede clinical symptoms and biochemical hypothyroidism by several years. Medical treatment is usually opted for majority of patients with Hashimoto's thyroiditis (HT). This includes both hypothyroid and hyperthyroid patients. In order to reduce thyroid volume and supplement thyroid hormone, patients with HT are typically treated conservatively with levothyroxine (L-T4) therapy. However, there are some cases where patients with HT are referred for surgery. Patients with HT, the thyroid gland tends to adhere more to its anatomical surroundings, which can increase the risk of damaging structures adjacent to the thyroid such as the parathyroid glands and the recurrent laryngeal nerve.
Keywords
HASHIMOTO’S; THYROIDECTOMY; THYROIDITIS
Supplementary Files
download 1492 10 (2).pdf
Statistics
Article View: 164
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.